Variation in the expression level of MALAT1, MIAT and XIST lncRNAs in coronary artery disease patients with and without type 2 diabetes mellitus

References

• Adamson, P.D., et al., 2018. Comparison of international guidelines for assessment of suspected stable angina: insights from the PROMISE and SCOT-HEART. JACC: cardiovascular imaging, 11 (9), 1301–1310.,
   PubMed Web of Science ®Google Scholar
• American Diabetes, A., 2010. Diagnosis and classification of diabetes mellitus. Diabetes care, 33 (Suppl 1), S62–S69.
   PubMedGoogle Scholar
• Anuurad, E., et al., 2009. Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians. Atherosclerosis, 205 (1), 290–295.
   PubMed Web of Science ®Google Scholar
• Chawla, A., Chawla, R., and Jaggi, S., 2016. Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian journal of endocrinology and metabolism, 20 (4), 546–551.
   PubMedGoogle Scholar
• Chow, S.J., and Wang, H., 2008. Sample size calculations in clinical research. 2nd ed. Chapman & Hall/CRC press.
   Google Scholar
• Dalen, J.E., et al., 2014. The epidemic of the 20(th) century: coronary heart disease. The American journal of medicine, 127 (9), 807–812.
   PubMed Web of Science ®Google Scholar
• Geiss, L.S., Herman, W.H., and Smith, P.J., 1995. Mortality in non-insulin-dependent diabetes. Diabetes in America, 2, 233–255.
   Google Scholar
• Gomes, H., et al., 2017. The function and therapeutic potential of long non-coding RNAs in cardiovascular development and disease. Molecular therapy nucleic acids, 8, 494–507.
   PubMedGoogle Scholar
• Haemmig, S., et al., 2017. Long noncoding RNAs in cardiovascular disease, diagnosis, and therapy. Current opinion in cardiology, 32 (6), 776–783.,
   PubMed Web of Science ®Google Scholar
• Hayward, P.D., et al., 2015. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. The New England journal of medicine, 373 (10), 978.
   PubMedGoogle Scholar
• He, X., et al., 2017. LncRNAs: key players and novel insights into diabetes mellitus. Oncotarget, 8 (41), 71325–71341.,
   PubMedGoogle Scholar
• Heidari, L., et al., 2019. Promoter methylation and functional variants in arachidonate 5-lipoxygenase and forkhead box protein O1 genes associated with coronary artery disease. Journal of cellular biochemistry, 120 (8), 12360–12368.,
   PubMed Web of Science ®Google Scholar
• Helgadottir, A., et al., 2006. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nature genetics, 38 (1), 68–74.
   PubMed Web of Science ®Google Scholar
• Ishii, N., et al., 2006. Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. Journal of human genetics, 51 (12), 1087–1099.
   PubMed Web of Science ®Google Scholar
• Jarroux, J., Morillon, A., and Pinskaya, M., 2017. History, discovery, and classification of lncRNAs. Advances in experimental medicine and biology, 1008, 1–46.
   PubMed Web of Science ®Google Scholar
• Kaikkonen, M.U., Lam, M.T., and Glass, C.K., 2011. Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovascular research, 90 (3), 430–440.
   PubMed Web of Science ®Google Scholar
• Li, J., Xuan, Z., and Liu, C., 2013. Long non-coding RNAs and complex human diseases. International journal of molecular sciences, 14 (9), 18790–18808.
   PubMed Web of Science ®Google Scholar
• Ogurtsova, K., et al., 2017. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes research and clinical practice, 128, 40–50.
   PubMed Web of Science ®Google Scholar
• Puthanveetil, P., et al., 2015. Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells. Journal of cellular and molecular medicine, 19 (6), 1418–1425.
   PubMed Web of Science ®Google Scholar
• Raut, S.K., and Khullar, M., 2018. The big entity of new RNA world: long non-coding RNAs in microvascular complications of diabetes. Frontiers in endocrinology, 9, 300.
   PubMed Web of Science ®Google Scholar
• Roberts, R., 2014. Genetics of coronary artery disease. Circulation research, 114 (12), 1890–1903.
   PubMed Web of Science ®Google Scholar
• Samir, A., Salama, E., and El Tayebi, H.M, 2018. The long non-coding RNA XIST: a new cornerstone in carcinogenesis. Journal of molecular and genetic medicine, 12 (2). doi:10.4172/1747-0862.1000356
   Google Scholar
• Sarrafzadegan, N., and Mohammmadifard, N., 2019. Cardiovascular disease in Iran in the last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Archives of Iranian medicine, 22 (4), 204–210.
   PubMed Web of Science ®Google Scholar
• Sathishkumar, C., et al., 2018. Linking a role of lncRNAs (long non-coding RNAs) with insulin resistance, accelerated senescence, and inflammation in patients with type 2 diabetes. Human genomics, 12 (1), 41.
   PubMedGoogle Scholar
• Sayols-Baixeras, S., et al., 2014. Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variants. The application of clinical genetics, 7, 15–32.
   PubMedGoogle Scholar
• Shi, T., Gao, G., and Cao, Y., 2016. Long noncoding RNAs as novel biomarkers have a promising future in cancer diagnostics. Disease markers, 2016, 9085195.
   PubMed Web of Science ®Google Scholar
• Sohrabifar, N., et al., 2019. MicroRNA-copy number variations in coronary artery disease patients with or without type 2 diabetes mellitus. Archives of physiology and biochemistry, 1–7.
   PubMed Web of Science ®Google Scholar
• Sun, X., and Wong, D., 2016. Long non-coding RNA-mediated regulation of glucose homeostasis and diabetes. American journal of cardiovascular disease, 6 (2), 17–25.
   PubMed Web of Science ®Google Scholar
• Tan, J., et al., 2019. LncRNA-MIAT increased in patients with coronary atherosclerotic heart disease. Cardiology research and practice, 2019, 6280194.
   PubMed Web of Science ®Google Scholar
• Tian, X., and Xu, G., 2015. Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis. BMJ open, 5 (9), e008653
   PubMed Web of Science ®Google Scholar
• Toraih, E.A., et al., 2019. [PROVISIONAL] Association of long non-coding RNA MIAT and MALAT1 expression profiles in peripheral blood of coronary artery disease patients with previous cardiac events. Genetics and molecular biology, 42 (3), 509–518.
   PubMed Web of Science ®Google Scholar
• Vausort, M., Wagner, D.R., and Devaux, Y., 2014. Long noncoding RNAs in patients with acute myocardial infarction. Circulation research, 115 (7), 668–677.
   PubMed Web of Science ®Google Scholar
• Yan, C., Chen, J., and Chen, N., 2016. Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability. Scientific reports, 6, 22640
   PubMed Web of Science ®Google Scholar
• Zhang, M., et al., 2016a. Down-regulation of lncRNA MALAT1 reduces cardiomyocyte apoptosis and improves left ventricular function in diabetic rats. International journal of cardiology, 203, 214–216.
   PubMed Web of Science ®Google Scholar
• Zhang, M., et al., 2016b. Involvement of long noncoding RNA MALAT1 in the pathogenesis of diabetic cardiomyopathy. International journal of cardiology, 202, 753–755.,
   PubMed Web of Science ®Google Scholar
• Zhang, X., Ding, L., and Sandford, A.J., 2005. Selection of reference genes for gene expression studies in human neutrophils by real-time PCR. BMC molecular biology, 6 (1), 4.
   PubMedGoogle Scholar
• Zhang, Y., et al., 2019. MicroRNAs or long noncoding RNAs in diagnosis and prognosis of coronary artery disease. Aging and disease, 10 (2), 353–366.,
   PubMed Web of Science ®Google Scholar
• Zhou, L., et al., 2015. Long non-coding MIAT mediates high glucose-induced renal tubular epithelial injury. Biochemical and biophysical research communications, 468 (4), 726–732.,
   PubMed Web of Science ®Google Scholar